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Abstract 
Background: Cerebral malaria and severe anaemia are the most common deadly complications of malaria, and are 
often associated, both in paediatric and adult patients, with hepatopathy, whose pathogenesis is not well character-
ized, and sometimes also with acute respiratory distress syndrome (ARDS). Here, two species of murine malaria, the 
lethal Plasmodium berghei strain NK65 and self-healing Plasmodium chabaudi strain AS which differ in their ability to 
cause hepatopathy and/or ARDS were used to investigate the lipid alterations, oxidative damage and host immune 
response during the infection in relation to parasite load and accumulation of parasite products, such as haemozoin.
Methods: Plasma and livers of C57BL/6J mice injected with PbNK65 or PcAS infected erythrocytes were collected 
at different times and tested for parasitaemia, content of haemozoin and expression of tumour necrosis factor (TNF). 
Hepatic enzymes, antioxidant defenses and lipids content and composition were also evaluated.
Results: In the livers of P. berghei NK65 infected mice both parasites and haemozoin accumulated to a greater extent 
than in livers of P. chabaudi AS infected mice although in the latter hepatomegaly was more prominent. Hepatic 
enzymes and TNF were increased in both models. Moreover, in P. berghei NK65 infected mice, increased lipid per-
oxidation, accumulation of triglycerides, impairment of anti-oxidant enzymes and higher collagen deposition were 
detected. On the contrary, in P. chabaudi AS infected mice the antioxidant enzymes and the lipid content and compo-
sition were normal or even lower than uninfected controls.
Conclusions: This study demonstrates that in C57BL/6J mice, depending on the parasite species, malaria-induced 
liver pathology results in different manifestations, which may contribute to the different outcomes. In P. berghei NK65 
infected mice, which concomitantly develop lethal acute respiratory distress syndrome, the liver tissue is character-
ized by an excess oxidative stress response and reduced antioxidant defenses while in P. chabaudi AS infected mice 
hepatopathy does not lead to lipid alterations or reduction of antioxidant enzymes, but rather to inflammation and 
cytokine burst, as shown earlier, that may favour parasite killing and clearance of the infection. These results may help 
understanding the different clinical profiles described in human malaria hepatopathy.
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(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Despite large investments and global interventions over 
the last century, malaria remains a leading cause of 
morbidity and mortality in humans with 212 million clin-
ical cases in 2015 and 429,000 deaths estimated world-
wide, 70% of which are children under 5 year of age [1]. 
The malaria infection can occur with fever and general-
ized sickness, and progress to severe anaemia or cerebral 
malaria, or can be asymptomatic. This range of clinical 
courses can be attributed to the host or to the parasites. 
In particular, the genetic background and the immune 
system of the host, the dynamics of transmission and 
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the virulence of the parasites have to be considered [2, 
3]. Hepatic involvement in cases of malarial infection is 
a well-recognized entity. Malaria hepatocellular dysfunc-
tion is characterized by an increase in the serum levels 
of bilirubin and aminotransferases, exceeding three times 
the upper limit of normal values. Malarial hepatopathy 
is associated with a higher incidence of cerebral malaria, 
shock, acute respiratory distress syndrome (ARDS) and 
acute kidney injury [4]. It occurs both in adult and pae-
diatric patients, although it is more common in adults 
[3, 4]. One suspected cause of malarial hepatopathy is 
related to the activation of liver macrophages that phago-
cytize haemozoin or parasitized red blood cells [5]. Focal 
hepatocyte necrosis, cholestasis and granulomatous 
lesions have been documented in all malarial nodules 
[4]. In malaria patients with jaundice, histopathological 
changes in the form of damaged hepatocytes, congestion 
of liver cells, haemozoin deposition, inflammatory infil-
trates, and cholestasis have been demonstrated [6, 7], as 
well as hyperplastic Kupffer cells [8].
The molecular basis of different manifestations of 
malaria using two species of murine Plasmodium, namely 
Plasmodium berghei strain NK65, and Plasmodium 
chabaudi strain AS have been recently investigated. Plas-
modium berghei NK65-infection results in lethal ARDS 
[9], whereas P. chabaudi AS-infection in C57Bl/6J is self-
healing after an initial peak of parasitaemia and recru-
descence, and does not induce lung pathology [10, 11]. 
Plasmodium berghei NK65 and P. chabaudi AS parasites 
produce different amounts of haemozoin (Hz), and it has 
been demonstrated that Hz is pathogenic in the lungs by 
inducing pulmonary inflammation [12, 13]. Moreover, 
in mice infected by P. berghei NK65, the development 
of ARDS is associated with biochemical modifications 
and lipid alterations of lung tissue and disruption of the 
molecular organization and lipid composition of alveolar 
surfactant [12].
Excess Hz deposition was shown in the livers of P. 
berghei NK65-infected mice compared to P. chabaudi 
AS mice, while hepatomegaly due to inflammation and 
cell recruitment was higher in P. chabaudi AS mice. Just 
as in the lungs, liver dysfunction with elevated serum 
ALT and AST levels and production of both pro- and 
anti-inflammatory cytokines were associated with the 
amount of haemozoin present in the livers of P. chabaudi 
AS-infected mice. It was intriguing that inflammation, 
measured as cell recruitment and cytokine production, 
was much less pronounced in P. berghei NK65 livers that 
had higher amounts of haemozoin than P. chabaudi AS 
livers. Since haemozoin, due to its haem iron content, is 
strongly pro-oxidant and immunosuppressive [14, 15] the 
present work aimed at investigating the extent of oxida-
tive damage, the lipid alterations and the antioxidant 
defences present in the liver tissue of C57BL/6J mice 
infected with P. berghei NK65, compared to mice infected 
with P. chabaudi AS.
Methods
Reagents
Unless otherwise specified, all biochemicals were pur-
chased from Sigma (Milan, Italy). Standard fatty acid 
methylesters were purchased from Alltech (Milan, Italy), 
silica gel plates (Kieselgel 60) and high performance thin 
layer chromatography (HPTLC) from Merck (Darmstadt, 
Germany).
Animals
The infection of C57BL/6J mice were performed by intra-
peritoneal injection of  104 P. berghei NK65 or P. chabaudi 
AS infected red blood cells, as described [9, 12]. Three 
different experiments were performed; 6 or 8 mice/group 
(control and infected mice) were used for each time point 
and used at day 8 or 10 after infection. The time intervals 
and the dose of parasites were chosen based on previous 
experience. All the data were in line with and confirmed 
our previous study [16]. Mice were euthanized by intra-
peritoneal injection of a lethal dose of sodium pentobar-
bital (200 µl at 60 mg/ml Nembutal) at day 8 or 10 post 
infection and blood was removed by heart puncture and 
centrifuged to separate plasma and RBC.
Preparation of biological specimens
Mice were perfused with 0.15  M NaCl containing 
0.2  mM butylhydroxytoluene (BHT) as an antioxidant, 
and livers were removed, weighted and homogenized in 
Precellys tubes in six volumes of a solution containing 
20 mM Tricine, 250 mM sucrose, 5 mM EDTA, 0.2 mM 
BHT (pH 7.4) and a protease inhibitor cocktail (Sigma, 
Milan, Italy).
Haemozoin determination
The content of Hz in the perfused livers was analysed 
by haem-enhanced chemoluminescence determination 
according to Deroost et  al. [13, 17]. The amount of Hz 
(pmol/mg tissue) was multiplied by the total weight of 
the liver and expressed as pmol or nmol haematin/organ.
Lipid analyses
The extraction of lipids in the liver was performed 
according to Folch [18]. Dried lipid extracts were dis-
solved in chloroform and saved at − 80  °C until further 
analysis. The content of phospholipid (PL) phosphorus 
was determined by the Bartlett procedure [19]. Choles-
terol (Cho), triglycerides (TG) and cholesterol esters 
(ChoE) were quantified by densitometric analysis (Camag 
Reprostar 3) after separation by HPTLC in hexane/
Page 3 of 9Scaccabarozzi et al. Malar J  (2018) 17:18 
diethyl ether/acetic acid (90:10:1 by vol.). A solution of 
10%  CuSO4 in 8%  H3PO4 was used to visualize the spots. 
The fatty acid composition of the lipid fractions was ana-
lysed by gas liquid chromatography according to Cor-
setto et al. [20]. The levels of thiobarbituric acid reactive 
substances were used to determinate the lipid peroxida-
tion, as previously reported [21] and expressed as pmoles 
of malondialdehyde (MDA).
Antioxidant enzymes and other analyses
Antioxidant enzymes and total glutathione 
(GSH  +  GSSG) were determined in the supernatant 
of liver homogenates obtained after a centrifugation at 
12000×g for 10  min. Protein concentration was deter-
mined by the Bradford assay (Bio-Rad, Hercules, CA) [22]. 
Catalase (CAT), glutathione reductase (GR) and superox-
ide dismutase (SOD) activity was determined according to 
Aebi et al. [23], Pinto et al. [24] and by a assay kit (Cayman 
Michigan, USA), respectively. Total GSH was determined 
spectrophotometrically by titration with 5-5′-dithiobis-2 
nitro benzoic acid (DTNB) according to Beutler [25]. 
The collagen content of livers, was determined by meas-
uring hydroxyproline in the tissue homogenates [26]. 
Liver damage was determined by measuring plasma lev-
els of serum alanine transaminase (ALT) and aspartate 
transaminase (AST) enzymes, according to manufactur-
er’s protocol (Teco Diagnostics, California, USA).
Quantitative reverse transcription‑polymerase chain 
reaction
The liver homogenates were used to extract and quantify 
total RNA and to synthetize cDNA. A quantitative PCR 
was performed on 25 and 12.5  ng cDNA with primer 
and probe sets from Applied Biosystems according to 
Deroost et al. [13]. Data were normalized to 18S riboso-
mal RNA levels.
Statistical analysis
The data are reported as mean  ±  standard deviation 
(SD). ANOVA test followed by Tukey’s multiple compari-
son test with GraphPad Prism 6.0 (Graphpad Software 
Inc., La Jolla, CA, USA) were performed to compare the 
groups and replicates. The differences were considered 
significant when p < 0.05. To eliminate possible artefacts 
(over- or under-estimation) due to hepatomegaly and 
hepatic oedema, all the biochemical parameters have 
been expressed as total content/liver.
Results
Malaria infection in mice
C57BL/6J mice were infected intraperitoneally with  104 
infected RBC (either P. berghei NK65 or P. chabaudi AS) 
and the development of parasitaemia was monitored 
every day whereas the liver pathology was checked on 
day 8 and 10 after the start of infection. These time inter-
vals and the parasite dose were chosen on the basis of 
the indications from previous experiments [9]. Parasitae-
mia was lower in P. chabaudi AS compared to P. berghei 
NK65 infected mice at both time points (Fig. 1a), whereas 
hepatomegaly was evident in P. chabaudi AS, but not in 
P. berghei NK65-infected mice, corroborating previous 
data [16] (Fig. 1b). Similarly, elevated levels of AST and 
ALT were detected in the serum of infected mice at both 
time points (Additional file 1, Panel A and B). Of notice 
is the observation that in P. berghei NK65 infected mice, 
AST levels were particularly increased over ALT levels, 
leading to an AST/ALT ratio of 3.9 and 5.9 at day 8 and 
10, respectively. Differently, in P. chabaudi AS infected 
mice the AST/ALT ratios was 1.5 and 1.2 at the same 
time intervals (Additional file 1, Panel C). These findings 
are consistent with the levels of parasitaemia in P. berghei 
NK65 mice since elevated AST levels may also reflect 
haemolysis in addition to liver damage [27]. Previous 
Fig. 1 Disease course in mice infected with P. berghei NK65 or P. chabaudi AS. C57BL/6J mice were injected intraperitoneally with  104 erythrocytes 
infected with P. berghei (PbNK65) or P. chabaudi AS (PcAS). Peripheral parasitaemia (a) and weights of the livers (b) were determined at day 8 and 10 
post infection. n = 15–16 mice for each time point and strain. Data are pooled from three different experiments performed in the same conditions. 
**p < 0.01; vs control; °p < 0.05 P. berghei NK65 vs P. chabaudi AS
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reports in a larger set of experiments confirm these 
observations. [16].
Differently from P. chabaudi AS-infected mice, livers 
from P. berghei NK65-infected mice also showed a dark-
brown coloration in agreement with the significantly 
higher hepatic Hz deposition (Fig.  2a). In parallel with 
these modifications, also the proinflammatory status of 
the liver changed during the infections with the different 
Plasmodium species. The mRNA levels of TNF increased 
during the progression of the disease in the livers of 
both P. berghei NK65 and P. chabaudi AS infected mice 
(Fig. 2b), but with a different kinetic and values. Collagen 
deposition, measured as hydroxyproline content, was sig-
nificantly higher with both parasite species at day 8 post 
infection with the highest levels in P. berghei NK65 livers. 
At day 10, the values returned to normal in both groups 
of mice, as those of control (Fig. 2c). Lipid peroxidation, 
expressed as total pmoles MDA/liver, was found to be 
significantly and time-dependently increased in mice 
infected with both Plasmodium species showing higher 
levels in P. berghei NK65 infected mice at either day post 
infection (Fig. 2d).
Oxidative stress response in the liver
The above findings, namely the increased levels of Hz and 
increased levels of MDA suggestive of oxidative stress in P. 
berghei NK65-livers, prompted us to investigate the status 
of the antioxidant defence systems in the infected livers as 
a determinant of tissue susceptibility to oxidative damage. 
The pattern of response in the two groups of infected mice 
was again different. As expected from the higher levels 
of lipoperoxidation, the liver extracts of P. berghei NK65 
infected mice were characterized by a lower CAT activ-
ity and lower levels of total glutathione (GSH + GSSG) at 
both days post infection (Fig. 3a, b). SOD activity was sig-
nificantly enhanced at day 10 post infection, whereas GR 
was not different from uninfected mice (Fig. 3c, d). On the 
contrary, P. chabaudi AS-infected mice showed CAT and 
SOD activity and GSH levels similar to control at both 
days post infection, whereas GR activity was higher at 
both time points (Fig. 3d).
Species‑specific lipid changes in infected livers
Liver dysfunction is generally associated with lipid altera-
tions. The lipid profile of infected livers was significantly 
Fig. 2 Hepatic haemozoin levels, oxidative damage and fibrosis in liver tissue of P. berghei NK65 or P. chabaudi AS infected mice. Hz content in liver 
tissue (pmol Hz/mg liver tissue) of P. berghei NK65 or P. chabaudi AS infected C57Bl/6J mice at day 8 and 10 post infection (a). Hepatic mRNA expres-
sion levels of TNF-α in non-infected and infected mice at day 8 or day 10 post infection determined by quantitative RT-PCR and normalized to 18S 
ribosomal RNA levels (b). OH-proline content (μg/mg protein) in non-infected and infected mice at day 8 or day 10 post infection (c); MDA content 
(pmol/liver) in non-infected and infected mice at day 8 or day 10 post infection (d). n = 6 mice/for each time point and group. *p < 0.05; **p < 0.01; 
***p < 0.0001 vs Control; °°p < 0.05; °°°p < 0.01 P. berghei NK65 vs P. chabaudi AS
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modified compared to control mice and different between 
the two species. TG levels were significantly higher in the 
P. berghei NK65- compared to P. chabaudi AS-infected 
livers (Fig.  4a). In addition, higher levels of ChoE, and 
lower levels of free Cho were seen with PbNK65 at both 
day 8 and 10 post infection, compared to control mice, 
whereas P. chabaudi AS-infected mice had higher levels 
of free cholesterol (Fig. 4b, c). Compared to control mice, 
PL were more strongly increased in P. chabaudi AS-
infected livers than in P. berghei NK65 at both days post 
infection (Fig. 4d), whereas no differences were found in 
the composition of the PLs due to infection (Fig. 5).
Modification in the fatty acid distribution between P. 
berghei NK65 vs P. chabaudi AS livers was also observed. 
Palmitic acid was significantly increased in P. chabaudi 
AS livers compared to control, whereas this was 
decreased in P. berghei NK65 together with palmitoleic 
acid. Among the polyunsaturated fatty acids, significantly 
higher amounts of linoleic acid (C18:2 n − 6) and lower 
levels of eicosatrienoic (C20:3 n  −  6) and arachidonic 
(C20:4 n −  6) acids were seen in P. berghei NK65 com-
pared to control (Table  1). These differences were less 
pronounced in P. chabaudi AS livers and limited to the 
changes of arachidonic acid (C20:4 n − 6) and docosap-
entaenoic acid (C22:5 n − 3). As a consequence of these 
changes, also the C18:2/C20:4 ratio was significantly 
increased in P. berghei NK65 compared to control or P. 
chabaudi AS.
Discussion
The pathogenesis of hepatic dysfunction in malaria is 
complex and not completely understood. Histopatho-
logical findings show congested and swollen hepatocytes, 
Kupffer cell hyperplasia, deposition of brown malarial 
pigment, mononuclear cell infiltration, micro-occlusion 
by parasitized RBC and, less frequently, steatosis and 
spotty and submassive necrosis [2, 7, 13, 16, 28]. Infec-
tion, inflammation and oxidative stress have been shown 
to induce multiple alterations in hepatic lipid and lipo-
protein metabolism [29]. The present study demon-
strates that blood stage malaria infection by P. chabaudi 
AS or P. berghei NK65 exerts different effects on the 
liver of C57BL/6J mice. Hepatomegaly was confirmed in 
P. chabaudi AS mice, as previously shown [16] as well 
as liver dysfunction suggested by the serum increase of 
the hepatic enzymes AST and ALT, especially at day 10 
post infection. The high AST levels lead to an AST/ALT 
ratio significantly higher in P. berghei NK65 compared to 
P. chabaudi AS. The AST/ALT index is used to discrimi-
nate the type of liver damage observed [27, 30] and a pro-
gressive increase in the AST/ALT ratio correlated with a 
decrease in liver functions, like in cirrhosis and fibrosis 
Fig. 3 Enzymes activity in the liver of C57Bl/6J mice infected by P. berghei NK65 or P. chabaudi AS. Catalase activity (a), total GSH (b), SOD activity 
(c) and glutathione reductase activity (d) were determined in the livers of non-infected and infected mice at day 8 and day 10 post infection. n = 8 
mice/group. Data are from one representative experiment out of three performed in the same conditions; *p < 0.05; **p < 0.01; ***p < 0.0001 vs 
control
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[31]. Since plasma clearance of AST is modulated by the 
activity of sinusoidal liver cells, during progressive fibro-
sis and cirrhosis, the functions of these cells are progres-
sively impaired resulting in a relative increase in AST 
levels [32]. In the case of malaria, in P. berghei NK65-
infected mice, an alternative hypothesis can be proposed. 
Elevated AST levels in absence of elevated ALT, in fact, 
may indicate haemolysis, since RBC contain AST. This 
has already been reported in sickle cell disease where the 
AST/ALT ratio has been used as haemolytic index [33]. 
In the models used for this work, the AST/ALT ratio may 
well indicate initial fibrosis in both species, as confirmed 
by the OH-proline increase at day 8 post infection, and 
increased haemolysis in P. berghei NK65-infected mice 
that develop higher parasitaemia than P. chabaudi AS 
mice. The latter leads to higher levels of Hz in the liver 
of P. berghei NK65- than in P. chabaudi AS-infected mice 
[16]. It is well known that Hz plays a crucial role in gen-
erating oxidative damage [12, 14, 15]. The higher content 
of Hz, free (pro-oxidant) haem derived from intravascu-
lar haemolysis and high parasitaemia are likely to con-
tribute to excessive oxidative stress response in P. berghei 
NK65 livers. TNF may also participate. A marginal role 
seems to be played by the inflammatory infiltrate, which 
is much less abundant in P. berghei NK65-infected liv-
ers than in P. chabaudi AS mice, in which increased liver 
Fig. 4 Alteration in the lipid profiles of the livers from uninfected, P. berghei NK65 or P. chabaudi AS infected mice. Mice infected with P. berghei NK65 
or P. chabaudi AS were dissected at day 8 and 10 post infection. The total content of liver triglycerides (TG) and phospholipids (PL) were deter-
mined as described in “Methods” (a and c). The content of ChoE and free Cho is shown in b and d, respectively. n = 8 mice for each condition. Data 
are from one representative experiment out of three performed in the same conditions *p < 0.05; **p < 0.01; ***p < 0.0001 vs Control; °p < 0.05; 
°°°p < 0.001 P. berghei NK65 vs P. chabaudi AS
Fig. 5 Phospholipids composition in liver from uninfected, P. berghei 
NK65 or P. chabaudi AS infected mice. The distribution of liver PL (µg 
PL/mg protein) was determined in uninfected and in P. berghei NK65- 
or P. chabaudi AS-infected mice at day 8 or 10 post infection. Data are 
from one representative experiment out of three performed in the 
same conditions. LPC lysophosphatidylcholine, SM sphingomyelin, PC 
phosphatidylcholine, PS phosphatidylserine, PI phosphatidylinositol, 
PE phosphatidylethanolamine, CD cardiolipine
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weight, histology and the correlation between hepatic 
inflammation, enzymes and haemozoin were demon-
strated [16].
The higher production of ROS in P. berghei NK65-
infected mice was confirmed by the elevated concentra-
tion of MDA, which is an index for the loss of structure 
and cell membrane integrity, and the concomitant deple-
tion of the antioxidant defence system, such as CAT 
and total GSH. GSH constitutes the first line of defence 
against free radicals and is a critical determinant of tissue 
susceptibility to oxidative damage. The increase of SOD, 
shown also in other models of liver damage [34], reveals 
the necessity of minimizing oxidative stress, which 
largely derives from the production of superoxide anion 
radicals. These changes seems to be associated with P. 
berghei NK65 infection, since they were not present in P. 
chabaudi AS-infected mice that showed only an increase 
of GR at both days post infection.
An important change observed in P. berghei NK65 vs 
P. chabaudi AS mice was the augmentation of the liver 
content of TG and cholesterol esters that indicates a 
potent stimulation of hepatic lipogenesis by P. berghei 
parasites [35]. This is in agreement with literature data 
showing that livers from P. berghei-infected mice con-
tain lipid droplets and myelin-like figures [36]. A signifi-
cant, although limited increase of TG was also present in 
P. chabaudi AS infected mice in agreement to the small 
neutral lipid inclusions observed by Seixas et al. [37]. Ele-
vated TG are a characteristic of liver pathologies of dif-
ferent aetiology, clinically defined as non-alcoholic fatty 
liver disease in which TG accumulate and plasma albu-
min and protein decrease.
On the contrary, higher amounts of PL and free Cho 
were present in P. chabaudi AS-infected mice compared 
to contr or P. berghei NK65-infected mice. This is pos-
sibly related to reticuloendothelial hyperplasia and/or 
cholestasis, similar to those reported in the same or other 
models of malaria infection [7, 38]. The fatty acid distri-
bution in the liver tissue of P. chabaudi AS or P. berghei 
NK65 infected mice at different days after the infection 
confirms the impairment (possibly induced by ROS) of 
the elongation/desaturation pathway from linoleic to ara-
chidonic acid and may explain the higher linoleic/arachi-
donic acid ratio in the liver of P. berghei NK65-infected 
mice [39]. These observations also contribute to explain 
the changes in the lipid content and composition that 
was reported in the lungs of P. berghei NK65 infected 
mice [12].
All together, these findings are in agreement with other 
models of P. berghei infection and support the hypothesis 
that ROS may play a critical role in the liver dysfunction 
caused by P. berghei NK65 parasites [35, 40]. Consistent 
with this hypothesis are also the signs of fibrosis, revealed 
by the elevated hepatic levels of hydroxyproline at day 8 
post infection in P. berghei NK65-infected mice. Indeed, 
it is well known that oxidative stress is one of the major 
stimuli of fibrosis [41]. Excess of ROS may induce severe 
liver damage followed by a phase of repair [42] dur-
ing which TGF-β1 on one hand limits the proliferative 
response of hepatocytes, and on the other hand, increases 
Table 1 Fatty acid distribution in the liver tissue of Plasmodium chabaudi AS or Plasmodium berghei NK65 infected mice 
at different days after the infection
Data are expressed as mean ± SD










C16:0 palmitic acid 20.76 ± 1.0 25.04 ± 0.8* 26.10 ± 0.1* 18.41 ± 0.9* 18.01 ± 0.2*
C16:1 palmitoleic acid 1.10 ± 0.2 1.24 ± 0.1 1.17 ± 0.1 0.63 ± 0.3* 0.59 ± 0.1*
C18:0 stearic acid 13.25 ± 1.6 12.80 ± 0.7 13.47 ± 1.1 13.54 ± 1.7 13.87 ± 0.9
C18:1 oleic acid 10.12 ± 1.5 9.98 ± 1.5 11.01 ± 1.2 10.52 ± 1.5 10.20 ± 1.0
C18:2 n − 6 linoleic acid 15.00 ± 1.4 17.4 ± 0.6 17.98 ± 1.2 22.19 ± 2.4** 23.01 ± 1.9**
C18:3 n − 3 α-linolenic acid 0.25 ± 0.1 0.22 ± 0.1 0.19 ± 0.1 0.21 ± 0.1 0.20 ± 0.1
C18:3 n − 6 γ-linolenic acid 0.17 ± 0.1 0.18 ± 0.1 0.17 ± 0.1 0.16 ± 0.1 0.19 ± 0.1
C20:3 n − 6 eicosatrienoic acid 1.20 ± 0.1 0.98 ± 0.2 1.10 ± 0.1 0.51 ± 0.1*** 0.49 ± 0.1***
C20:4 n − 6 arachidonic acid 22.02 ± 1.1 19.99 ± 0.8* 18.97 ± 1.0* 16.81 ± 1.4*** 16.01 ± 1.2***
C20:5 n − 3 eicosapentaenoic acid 0.29 ± 0.1 0.22 ± 0.1 0.30 ± 0.1 0.21 ± 0.1 0.29 ± 0.1
C22:5 n − 3 docosapentaenoic acid 0.38 ± 0.1 0.57 ± 0.1* 0.60 ± 0.2* 0.37 ± 0.1 0.39 ± 0.1
C22:6 n − 3 docosahexanoic acid 9.28 ± 0.7 9.26 ± 1.2 9.40 ± 1.0 9.79 ± 0.6 9.70 ± 0.9
C18:2/C20:4 0.68 ± 0.1 0.87 ± 0.1 0.95 ± 0.1* 1.32 ± 0.1** 1.44 ± 0.2***
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the production of collagen and other extracellular matrix 
proteins. Submicroscopical signs of fibrosis were evident 
also in P. chabaudi AS-infected mice, although at a lower 
extent. Interestingly, at day 10 post infection, the amount 
of hydroxyproline decreased with both parasite species, 
becoming similar to control mice. The hypothesis that 
inflammation may lead to the activation of matrix metal-
loproteinases (MMPs) is under investigation. MMPs are 
proteolytic enzymes able to degrade different proteins of 
the extracellular matrix (e.g. collagen, laminin, fibronec-
tin) and modulate cytokine and chemokine activity in 
cases of severe inflammation. Previous data indicated 
that, in the liver of C57Bl/6J mice infected with P. berghei 
ANKA, the activity of MMPs is significantly increased 
[43]. Furthermore, several in vitro studies have shown a 
TNF-dependent induction of MMPs at both mRNA and 
protein levels in monocytes fed with natural Hz [16, 44].
Conclusion
In conclusion, this study demonstrates that, in C57BL/6J 
mice, P. berghei NK65 and P. chabaudi AS parasite spe-
cies induce liver pathology in a different manner. In 
particular, in P. berghei NK65 infected mice, which suc-
cumb of malaria ARDS, it seems that an excess oxidative 
response predominates, as demonstrated by the altera-
tion of the liver anti-oxidant enzymes, the increased 
MDA levels and the accumulation of TG. These changes 
are related to the high parasitaemia, the liver Hz depo-
sition and the modification in protein content and lipid 
profile. These alterations are less pronounced with P. 
chabaudi AS, which develops a self-limiting infection, 
with lower parasitaemia and Hz deposition, and thus 
less oxidative stress. The cell infiltrate and the cytokine 
burst occurred at the peak of the infection may suggest 
an inflammatory liver response, which precedes parasite 
clearance [16].
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